Junren Zhang
YOU?
Author Swipe
View article: New uses of halofuginone to treat cancer
New uses of halofuginone to treat cancer Open
View article: Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors
Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors Open
Canine mammary tumors (CMT) can severely compromise the life quality of the affected dogs through local recurrence, distant metastases and ultimately succumb to death. Recently, more attention has been given to the potential antimetastatic…
View article: Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis
Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis Open
Taken together, HTPM could be applied as a potential anticancer agent for TNBC by oral administration.
View article: Tel2 regulates redifferentiation of bipotential progenitor cells via Hhex during zebrafish liver regeneration
Tel2 regulates redifferentiation of bipotential progenitor cells via Hhex during zebrafish liver regeneration Open
Upon extensive hepatocyte loss or impaired hepatocyte proliferation, liver regeneration occurs via biliary epithelial cell (BEC) transdifferentiation, which includes dedifferentiation of BECs into bipotential progenitor cells (BP-PCs) and …
View article: Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells
Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells Open
The findings from this study indicate that HTPMs holds great clinical potential for treating triple-negative breast cancer.